Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

about

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

Item

http://www.wikidata.org/entity/Q49393089

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

@en

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

@nl

type

Item

label

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

@en

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

@nl

prefLabel

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

@en

Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

@nl

P1476

Notch signaling triggers the tumor heterogeneity of small cell lung cancer

@en

P2093

Margarete Odenthal

http://www.w3.org/2001/XMLSchema#string

Reinhard Büttner

http://www.w3.org/2001/XMLSchema#string

P2860

Notch Signaling in Neuroendocrine Tumors

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Neuroepithelial body microenvironment is a niche for a distinct subset of Clara-like precursors in the developing airways

The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands

The intracellular region of Notch ligands Dll1 and Dll3 regulates their trafficking and signaling activity

A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer.

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.

Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

P304

4884-4888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2017.11.104

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lydia Meder

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312683

http://www.w3.org/2001/XMLSchema#string

P932

5757017

http://www.w3.org/2001/XMLSchema#string